4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-029053
Chief Medical Officer sold 17,500 shares at an average $22.85 ($399,901)
- Chief Medical Officer acquired 7,812 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ho Carole · Chief Medical Officer
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-08 | Exercise or conversion : show line 1 in the form | +2,613 | $5.28 | $13,797 | 2,613 | D |
| 2019-05-08 | Sale : show line 2 in the form | −2,613 | $23.50 | $61,406 | 0 | D |
| 2019-05-08 | Sale : show line 3 in the form | −3,162 | $23.51 | $74,339 | 110,332 | I |
| 2019-05-09 | Exercise or conversion : show line 4 in the form | +2,653 | $5.28 | $14,008 | 2,653 | D |
| 2019-05-09 | Sale : show line 5 in the form | −2,453 | $22.86 | $56,076 | 200 | D |
| 2019-05-09 | Sale : show line 6 in the form | −200 | $23.58 | $4,716 | 0 | D |
| 2019-05-09 | Sale : show line 7 in the form | −3,010 | $22.83 | $68,718 | 107,322 | I |
| 2019-05-09 | Sale : show line 8 in the form | −200 | $23.60 | $4,720 | 107,122 | I |
| Open-market sales · 17,500 sh · avg $22.85 · $399,901 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-05-08 | Exercise or conversion : show line 12 in the form Stock Option (right to buy) | −2,613 | 91,138 | D |
| 2019-05-09 | Exercise or conversion : show line 13 in the form Stock Option (right to buy) | −2,653 | 88,485 | D |
| 2019-05-10 | Exercise or conversion : show line 14 in the form Stock Option (right to buy) | −2,546 | 85,939 | D |
Loading xslF345X03/doc4.xml…